Literature DB >> 19709170

Lung cancer in a health area of Spain: incidence, characteristics and survival.

J M García Prim1, F J González Barcala, J Paz Esquete, A Pose Reino, A Fondevila López, L Valdés Cuadrado.   

Abstract

To examine the incidence, characteristics, therapeutic approach and survival of diagnosed lung cancer (LC) in the Santiago de Compostela Health Area. A retrospective study was carried out on LC for a period of 3 years. Of the 481 cases collected, 92.7% were male. The median age was 66.93 years. The crude incidence for men and women was 80.71 and 5.84 per 100,000 inhabitants respectively. Among the non-small cell lung cancers (NSCLC), 68.1% were diagnosed in stage IIIB or IV. The cancer had already spread in 62.2% of the small cell lung cancer (SCLC). Chemotherapy was used in 51.6% of patients. The survival probability from the first to the fifth year was 47.7%, 24.3%, 12.9%, 10% and 8.9% respectively. The median survival at 5 years was 12.12 months for NSCLC, rising to 29.8 months in stage I, and 8.85 months in SCLC. In our Health Area LC occurs more often in men, in whom the prevalence of smoking is very high. The most common histology type was squamous cell carcinoma. In the majority of cases, the diagnosis is made in the advanced stages, which accounts for the low percentage of surgical treatments and the short survival.

Entities:  

Mesh:

Year:  2009        PMID: 19709170     DOI: 10.1111/j.1365-2354.2008.01008.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  3 in total

1.  Integrated analysis reveals five potential ceRNA biomarkers in human lung adenocarcinoma.

Authors:  Yu Liu; Deyao Xie; Zhifeng He; Liangcheng Zheng
Journal:  PeerJ       Date:  2019-04-29       Impact factor: 2.984

2.  Economic burden of brain metastases in non-small cell lung cancer patients in South Korea: A retrospective cohort study using nationwide claims data.

Authors:  Yoon-Bo Shim; Joo-Young Byun; Ju-Yong Lee; Eui-Kyung Lee; Mi-Hai Park
Journal:  PLoS One       Date:  2022-09-20       Impact factor: 3.752

3.  Pattern of use of radiotherapy for lung cancer: a descriptive study.

Authors:  Isabel Tovar; Jose Expósito; Javier Jaén; Enrique Alonso; Miguel Martínez; Rosa Guerrero; Juan P Arrebola; Rosario Del Moral
Journal:  BMC Cancer       Date:  2014-09-23       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.